Drug & Diagnostic Development 2012

Skip to Navigation


  • Date: Aug 5 - Aug 7, 2012
  • Source: http://www.ibclifesciences.com/DrugDisc/overview.xml
  • Channels: Proteomics & Genomics / Ion Chromatography / Gas Chromatography / HPLC / Electrophoresis / Proteomics / Base Peak / Atomic
  • Type: Conference
  • Location: The Westin, Market Street, San Francisco, CA, United States of America

Click here to view event website

thumbnail image: Drug & Diagnostic Development 2012

Drug & Diagnostic Development 2012 highlights innovations in antibody drug development, enabling genomic technologies and clinical biomarker strategies that are translating a better understanding of disease biology into clinical applications, leading to new therapeutics and diagnostics for cancer and other diseases.

Antibody-Drug Conjugates, Bispecifics & Empowered Antibodies

  • Next-Generation Antibody-Drug Conjugates
  • Empowered Antibodies & Bispecifics

Next-Gen Sequencing Applications & Translational Technologies

  • Clinical & Research Applications of Next-Generation Sequencing
  • Translational Biology & Technology

The Future of Rx/Dx Summit

  • Rx/Dx Development, Commercialization & Collaboration Models
  • Future Clinical Diagnostics

Clinical Biomarkers & New Frontiers in Cancer

  • Clinically-Relevant Biomarkers
  • New Frontiers in Cancer: Novel Clinical Paradigms

Contact Details

  • Email: reg@ibcusa.com

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in separation science? Visit our sister site separationsNOW.com

Copyright © 2018 John Wiley & Sons, Inc. All Rights Reserved